Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Niedermann

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Cancers|November 27, 2021
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic MalignanciesEleni Gkika, Sonja Adebahr, Anton Brenner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programmingLaiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Blood|November 22, 2014
Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiencyPolina Stepensky, Anne Rensing-Ehl, Ruth Gather, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung CancerLimei Yin, Jianxin Xue, Rui Li, et al.
Clinical and Translational Radiation Oncology|February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature reviewLara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
Cancer Letters|August 18, 2021
RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Cancer Letters|April 24, 2022
Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399]Sanaz Taromi, Elke Firat, Alexander Simonis, et al.
Cancer Letters|April 29, 2022
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Cancers|November 27, 2021
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic MalignanciesEleni Gkika, Sonja Adebahr, Anton Brenner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programmingLaiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Blood|November 22, 2014
Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiencyPolina Stepensky, Anne Rensing-Ehl, Ruth Gather, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung CancerLimei Yin, Jianxin Xue, Rui Li, et al.
Clinical and Translational Radiation Oncology|February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature reviewLara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
Cancer Letters|August 18, 2021
RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Cancer Letters|April 24, 2022
Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399]Sanaz Taromi, Elke Firat, Alexander Simonis, et al.
Cancer Letters|April 29, 2022
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Elke Firat, Alexander Simonis, et al.
Pageof 8